TIDMIIG

RNS Number : 0009V

Intuitive Investments Group plc

05 August 2022

5 August 2022

Intuitive Investments Group plc

("IIG" or the "Company")

Investment in PneumoWave Limited

Intuitive Investments Group plc (AIM: IIG), a closed-end life sciences investment company which owns the entirety of Sanondaf, a specialist disinfection and hygiene services business, has invested a further GBP100,000 into existing portfolio company PneumoWave Limited ("PneumoWave"), formerly known as Altair Medical. This equity investment is a bridge, by way of advance subscription agreement, to a Series A round of circa GBP7.5 million, which PneumoWave is looking to close in October 2022. IIG has previously invested GBP350,000 in PneumoWave, representing a 6.55 per cent. interest in PneumoWave's issued share capital.

PneumoWave is developing a biosensor and real time analysis platform that provides fully automated data capture, analysis, notification and response management for serious respiratory events that require rapid response. Its focus initially is on opioid induced respiratory depression, now the leading cause of accidental death in most developed countries and which claimed the lives of approximately 80,000 in the US and UK in 2021 alone.

The technology is being developed by clinicians to ensure maximum uptake across the diverse range of patient groups affected by inadvertent overdose, in hospitals and at home, from both therapeutic and illicit opioids. PneumoWave deploys proprietary algorithms and artificial intelligence on the clinical datasets to identify digital bio markers with predictive and preventive potential.

In 2020, PneumoWave was awarded the Breakthrough Medical Device designation from the U.S. Food and Drug Administration and is targeting Class 2 clearance in the US via the De Novo pathway in the first quarter of 2024. PneumoWave has also achieved Class 1 UK Conformity Assessed clearance.

PneumoWave has three opioid-focused clinical trials underway, having identified digital biomarkers for opioid overdose, it is aiming to prevent deaths in clinical trials in the first half of 2023. A further seven clinical trials are in process or due to start before the end of 2022.

Additional information relating to PneumoWave can be found at: https://pneumowave.com/

Stewart White, Chairman of IIG's Advisory Panel, is a Non-executive Director of PneumoWave.

For further information, please contact:

 
 Intuitive Investments Group plc                                            www.iigplc.com 
 Julian Baines, Non-Executive Chairman                                     Via Walbrook PR 
  Robert Naylor, CEO 
 
 SP Angel Corporate Finance LLP - 
  Nominated Adviser                                                   +44 (0) 20 3470 0470 
 Jeff Keating / David Hignell / Kasia 
  Brzozowska 
 Turner Pope Investments (TPI) Ltd 
  - Broker                                                            +44 (0) 20 3657 0050 
 Andrew Thacker / James Pope 
 
 Walbrook PR Limited - Media & Investor    +44 (0)20 7933 8780 or intuitive@walbrookpr.com 
  Relations 
                                                            +44 (0) 7980 541 893 / +44 (0) 
 Paul McManus/ Sam Allen                                                      7502 558 258

About Intuitive Investments Group plc

The Company is an investment company seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the chairman of the Investment Committee, David Evans, to seek to generate capital growth over the long term for shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCBKQBDABKDFFK

(END) Dow Jones Newswires

August 05, 2022 02:00 ET (06:00 GMT)

Intuitive Investments (LSE:IIG)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Intuitive Investments Charts.
Intuitive Investments (LSE:IIG)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Intuitive Investments Charts.